Dolichol-mediated enhanced protein N-glycosylation in experimental diabetes. A possible additional deleterious effect of hyperglycemia

Journal of Diabetes and its Complications

Volumn 11, Issue 4, 1997, Pages 236-242

  Bar On, Hanoch ^a   Nesher, Gideon ^b   Teitelbaum, Aliza ^a   Ziv, Ehud ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DEOXYGLUCOSE; DOLICHOL; ENZYME; GLUCOSAMINE; GLYCOSYLTRANSFERASE; LEUCINE; OLIGOSACCHARIDE; SECRETORY PROTEIN; TUNICAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; GLYCOPROTEIN SYNTHESIS; HYPERGLYCEMIA; LIVER CELL; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; RAT;

ANIMALS; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOLICHOL; GLUCOSAMINE; GLYCOSYLATION; HYPERGLYCEMIA; LEUCINE; LIVER; MALE; PROTEINS; RATS; TUNICAMYCIN;

EID: 0030953071     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00066-9     Document Type: Article

References (32)

1. Gabbay KH: The sorbitol pathway and the complications of diabetes. N Engl J Med 288:831-836, 1973.
2. Ward JD, Baker RWR, Davis BH: Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous system. Diabetes 21:1173-1178, 1972.
3. Greene DA, Lattimer SA: Pathogenesis and prevention of diabetic neuropathy. Diabetes Metab Rev 4:201-221, 1988.
4. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537, 1984.
5. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988.
6. Brownlee M: Glycation and diabetic complications (Lilly lecture - 1993). Diabetes 43:836-841, 1993.
7. Spiro RG, Spiro MJ: Effect of diabetes on the biosynthesis of the renal basement membrane. Diabetes 20:641-648, 1971.
8. Spiro RG: Search for a biochemical basis of diabetic microangiopathy. Diabetologia 12:1-14, 1976.
9. Sharma C, Dalferes ER, Radhakrishnamurthy B, De-Paolo CJ, Berenson GS: Hepatic glycoprotein synthesis in streptozotocin diabetic rats. Biochem Int 15:395-401, 1987.
10. Berry EM, Ziv E, Bar-On H: Protein and glycoprotein synthesis and secretion by the diabetic liver. Diabetologia 19:535-540, 1980.
11. Berry EM, Ziv E, Bar-On H: Lipoprotein secretion by isolated perfused livers from streptozotocin-diabetic rats. Diabetologia 21:402-408, 1981.
12. Tepperman HM, DeWitt J, Tepperman J: The effects of streptozotocin diabetes on the activities of rat liver glycosyl-transferases. Diabetes 32:412-415, 1983.
13. Spiro RG: Role of insulin in two pathways of glucose metabolism: in vivo glucosamine and glycogen synthesis. Ann NY Acad Sci 82:366-373, 1959.
14. Green M, Miller LL: Protein catabolism and protein synthesis in perfused livers of normal and alloxan-diabetic rats. J Biol Chem 235:3203-3208, 1960.
15. Marsh JB: Effect of fasting and alloxan diabetes on albumin synthesis by perfused rat liver. Am J Physiol 201:55-57, 1961.
16. Zahlten RN, Stratman FW: The isolation of hormone-sensitive rat heptocytes by a modified enzymatic technique. Arch Biochem Biophys 163:600-608, 1974.
17. Tkacz JS, Lampen JO: Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. Biochem Biophys Res Commun 65:248-257, 1975.
18. Datema R, Lezica RP, Robbins PW, Schwartz R: Deoxyglucose inhibition of protein glycosylation: Effects of nucleotide deoxysugars on the formation of glycosylated lipid intermediates. Arch Biochem Biophys 206:65-71, 1981.
19. Mans RJ, Novelli GD: A convenient, rapid and sensitive method for measuring the incorporation of radioactive amino acids into protein. Biochem Biophys Res Commun 3:540-543, 1960.
20. Yamada K, Yokohama H, Abe S, Katayama K, Sato T: High-performance liquid chromatographic method for the determination of dolichols in tissues and plasma. Anal Biochem 150:26-31, 1985.
21. Astrand I, Fries E, Chojnacki T, Dallner G: Inhibition of dolichol phosphate biosynthesis by compactin in cultured rat hepatocytes. Eur J Biochem 155:447-452, 1986.
22. Heifetz A, Keenan RW, Elbein AD: Mechanism of action of tunicamycin on the UDP-GlcNAc: Dolichyl-phosphate GlcNAc-1-phosphate transferase. Biochemistry 18:2186-2192, 1979.
23. Elbein AD: Inhibitors of the biosynthesis and processing of n-linked oligosaccharide chains. Ann Rev Biochem 56:497-543, 1987.
24. Tavares A, Coolbear T, Hemming FW: Increased hepatic dolichol and dolichol phosphate-mediated glycosylation in rats fed cholesterol. Arch Biochem Biophys 207:427-436, 1981.
25. Carson DD, Earles BJ, Lennarz WJ: Enhancement of protein glycosylation in tissue slices by dolichylphosphate. J Biol Chem 256:11552-11557, 1981.
26. Koh G, Robinson KA, Buse MG: Delayed processing of the insulin proreceptor by hepatocytes from diabetic rats. Biochem Biophys Res Commun 204:725-731, 1994.
27. Keller RK, Nellis SW: Quantitation of dolichol phosphate and dolichol in major organs of the rat as a function of age. Lipids 21:353-355, 1986.
28. Daniels I, Hemming FW: Changes in murine tissue concentrations of dolichol and dolichol derivatives associated with age. Lipids 25:586-592, 1990.
29. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
30. Tonino RP, Minaker KL, Rowe JW: Effect of age on systemic delivery of oral glucose in men. Diabetes Care 12:394-398, 1989.
31. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. J Biol Chem 266:4706-4712, 1991.
32. Robinson KA, Sens DA, Buse MG: Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Diabetes 42:1333-1346, 1993.